Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

MPH322 Musculoskeletal - RA > 3. Rheumatoid Arthritis > Flashcards

3. Rheumatoid Arthritis Flashcards

(68 cards)

Start Studying
1
Q

Main aim of treatment of rheumatoid arthritis

A
  • Relieve pain and inflammation

- Prevent joint destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is rheumatoid arthritis?

A

An inflammatory autoimmune disease of cellular and humeral components of immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

5 step potential progression of rheumatoid arthritis

A

Induction - Caused by genes, host factors and environment
Chronicity - Chronic phase - APC (antigen presenting cells) activate T-cells that activate B cells. Which produce cytokines, chemokines and growth factors.
Effector cells - Macrophages, synoviocyte and osteoclasts
Pathology - Cause inflammation and tissue damage
Outcome - Pain, stiffness, swelling, tenderness
- Deformities and disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When treating, should we target to treat inflammation and tissue damage

A

Inflammation - we should never try to target osteoclasts as treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for Rheumatoid Arthritis

A

Female - inc by post-partum and breast feeding

Cigarette smoke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a pannus?

A

An abnormal layer of fibrous material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 3 main cytokines involved in the cytokines

A

TNF alpha
IL-17
TH-17 and TH-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Role of COX enzyme.

What does each isoform do?

A

Produce PG from arachidonic acid

COX 1 - Constitutive enzyme found in constant levels and various tissues
COX 2 - inducible enzyme - levels are low in most tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does COX 1 do?

What does aspirin do?

A

Participates in the synthesis of PG

  • Catalyses the formation of TXA2 in the platelets leading to aggregation
  • Irreversibly inhibit COX1 by acetylation of the SER529
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Role of PG

A

Cytoprotective effect on the GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does COX 2 do?

A

More selective active site there for it has selective binding
- Inhibit the production of prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Difference between COX 1 and 2?

A

COX2 has a larger active site due to a different amino acid sequence. Therefore it is selective to larger inhibitors

Gives anti-inflammatory side effects with less side-effects
- Lower tendency to produce GI bleeding/ peptic ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the function of PG and Thromboxane?

A

PG - E2 and I2 - Pain and inflammation

Thromboxane - TxA2 - Vasoconstriction and inc platelet aggregation - Thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NSAID side effects and symptoms

A 
GI tract 
- Heartburn 
- Dyspepsia 
- Abdominal pain 
Serious - Ulceration and bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List NSAIDs by most COX-2 selective to least selective

A
  • Celecoxib
  • Meloxicam, Diclofenac etc
  • Ibuprofen and Naproxen
  • Aspirin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different risks associated with selectivity of COX-2 and COX-1 enzymes

A

COX-2 - Cardiovascular risk

COX-1 - Gastrointestinal Risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What MHRA advice has been given for Diclofenac?

A

Patients with serious underlying heart conditions e.g heart failure, heart disease, circulatory problems or previous MI or stroke should no longer use diclofenac.

Patients that smoke, have high blood pressure , raised cholesterol, diabetes or history of smoking should only use after careful consideration with their GP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name 3 never COX-2 Inhibitors

A
  • Etoricoxib
  • Parecoxib
  • Lumiracoxib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Increased conc of what are found in synovial fluid of patients with RA

A

IL-1 and TNFa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Roles of IL-1 and TNFa

A

Act synergistically to increase production of enzymes that degrade components of cartilage matrix

  • increase expression of adhesion molecules on endothelium, contributing to the migration of neutrophils and lymphocytes from the circulation
  • Stimulate pro-inflammatory mediators e.g IL-8, PGE2 and IL-6§
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pro inflammatory effects of IL-1

A

increase in:

  • ^ TNFa
  • ^ Osteoclast activation
  • ^ Angiogenic factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Proinflammatory effects of TNFa

A

increase in:

  • ^ IL-1
  • ^ Cell Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Proinflammatory effects of both IL-1 and TNFa

A

Increase in:

  • ^ COX-2
  • ^ PGE2
  • ^ NO
  • ^ Adhesion Molecules
  • ^ Chemokines
  • ^ Collagenases
  • ^ IL-6
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How does RA first present itself?

A

Stiffness in one or more joints,

- Usually accompanied by pain on movement and by tenderness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
List 7 types of criteria for RA
- Morning stiffness - Arthritis of 3 or more joints - Arthritis of hand joints - Symmetric arthritis - Rheumatoid nodules - Serum rheumatoid factor - Radiographic changes to RA
26
What are rheumatoid nodules, how do we treat?
- Occurs in almost seropositive patients - Central area of fibrinoid material surrounded by proliferating mononuclear cells - We do not treat
27
3 investigatory tests
- FBC - Normochromic/normocytic anaemia and thrombocytosis - ESR and CRP are raised in proportion to inflammation activity - Radiology - Xray shows joint narrowing or erosion - Synovial fluid - sterile with high neutrophil count
28
What 4 blood markers do we look for?
- ESR - The more rapidly the cells settle the more inflammation in the joints - inc in fibrinogen, inc in clotting speed - CRP - protein produced in the liver when there us inflammation anywhere - more sensitive measure than ESR - RF - non specific auto antibody found in blood of patients with RA - does not specifically mean that they will have RA - Anti-CCP antibodies - these are antibodies to proteins altered by inflammation - these are rarely found in patients without rheumatoid arthritis but not always in patients with RA
29
What is DAS28? Is it reliable?
- Disease activity score in 28 joints - provides number on scales 0-10 - High - >5.1 - Medium - 3.2-5.1 - Low 2.6-3.2 - Not always - If only the feet are affected this could be misleadingly low
30
How do we treat symptoms and flares? Dose?
NSAID or COX-2 inhibitor - Co-prescribe with PPI - give lowest effective dose Glucocorticoid therapy - only in flares - not for long term due to SE
31
Initial treatment
Monotherapy - Conventional DMARDs - Methotrexate, leflunomide, sulfasalazine - Can also have hydroxychloroquine, escalate as tolerated
32
4 suggested MOA for Methotrexate?
Suggested MOA - - inhibition of purine and pyrimidine synthesis - supression of transmethylation reactions with accumulation of polyamines - Reduction of antigen-dependant T-cell proliferation - Promotion of adenosine release with adenosine-mediated to suppress of inflammation
33
Why is methotrexate favourable?
Rapid onset (6-8), good efficacy, favourable toxicity profiles, administration and low cost
34
What is the starting dose for methotrexate? do we monitor?
- 5-10mg orally then inc according to max weekly dose 20mg - Also take folic acid 5mg to reduce side effects - not on the same day - Hepatotoxicity and bone marrow
35
How does methotrexate block purine and pyridine synthesis?
- Inhibition of Dihydrofolate reductase(DHFR) decreases tetrahydrofolte (THF) levels - Results in attenuated DNA/protein/ lipid methylation - inhibition of thamidylate synthase (TS) interference with DNA synthesis - Inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide(AICAR) transformylase blocs de novo purine synthesis
36
How do we prevent methotrexate toxicities?
Folic acid supplements 1-5mg per day - this gives no impact on the therapeutic effects
37
What is the typical dose of sulphasalazine? when do we use it?
500mg/day increasing by 500mg weekly to 2-3g a day added to methotrexate or alone if the patient has methotrexate intolerance
38
What do we monitor for sulphasalazine?
FBC, urinalysis every 4 weeks - ask patient about skin rash or ulceration within each visit
39
Side effects for sulphasalazine?
Cough, diarrhoea, nausea, dizziness, fever
40
What is the mechanism of action for leflunomide?
Inhibition of dihydroorate dehydrogenase(DHODH) leads to decrease rUMP(uridine monophosphate), decreased DNA and RNA synthesis Inhibition of T-cell proliferation and G1 cell cycle arrest
41
What is the typical dose for leflunomide?
100mg daily for 3 days then 10-20mg once daily
42
What are the side effects of leflunomide?
Life threatening liver toxicity in first 6 months
43
How do we monitor leflunomide?
FBC & FLTs every 2 weeks for the first 6 months | then every 6 weeks
44
What is hydroxychloroquine?
used to treat palindromic rheumatism
45
What do we monitor with hyroxychloraquine?
Monitor any visual impairments
46
What is the typical dose for hydroxychloroquine?
200-400mg daily max. 6.5mg/kg daily should only be given on expert advice
47
Summary of CDMARDs - Mechanism of action? - What do they do? - Side effects? - Monitoring? - Time of response?
- Unclear - inhibit release of inflammatory cytokines - Majority cause bone marrow and hepatic toxicity - Full blood count, liver function tests, electrolytes are routinely monitored - typically 6 weeks to 3 months
48
What do bDMARDs target?
- TNFa - IL-6 - T-Cells - B-Cells
49
When do we use bDMARDs?
If cDMARDs monotherapy does not work
50
Name different types of biological agents:
- Monoclonal antibodies - - Infliximab - Murine - Adalimumab - Human - Recombinant p75 TNF receptor - Etanercept - PEGylated Fab' fragment - Certolizumab pegol
51
What is sarilumab?
human monoclonal antibody against the IL-6 receptor
52
What is etanercept? What is the dose? what is the SE?
Anti-TNFa agent - 25mg twice weekly or 50mg once weekly - injection site reactions, infections and allergic reaction
53
What is the typical dose for infliximab? Common adverse effects? When is it contraindicated?
3mg/kg at weeks 0,2,6 then every 8 weeks - acute infusion-related reactions, infections, delayed hypersensitivity - People with moderate or severe heart failure, those withy TB
54
What is the typical dose for adalimumab? | What does it target?
40mg once every 2 weeks | - TNFa
55
What does Golimumab target?
TNFa
56
What is Tolicizumab?
Anti IL-6
57
What does IL-6 do?
- Cause chronic inflammation - Neutrophils, Macrophage, T-cells - joint destruction - RANKL - increased platelets - Bone marrow - Decreased RBC - Bone Marrow - antibody production - B-cells
58
When do we use abatacept?
in combination with methotrexate - patients with moderate to severe active RA - patients with insufficient response or intolerance - including at least 1 TNFa
59
How do we administer abatacept?
30 minute intravenous infusion after this it is repeated at week 2, 4 and then every 4 weeks after that 14 infusions in first year - 13 the year after
60
What is JAK? Give an example
Janus kinase inhibitors - Tofacitinib - JAK1/JAK3 - Baraicitinib - JAK1/JAK2
61
What is Rituximab? What does it do?
Genetically engineered chimeric monoclonal antibody | - decreases b-cell targeting cells bearing the CD20 surface marker
62
When do we use rituximab?
Combination with methotrexate for treatment of adults with severe rheumatoid arthritis with inadequate response or intolerance to other DMARDs including one or more TNF inhibitor
63
How is Rituximab administered?
Given as two 1000mg IV infusions | - 2 weeks apart
64
What is the side effects of Rituxumab?
Infections
65
How does Rituximab work?
TNFa blockade and IL-1 receptor antagonism significantly reduce disease activity
66
What are the advantages(1) and disadvantages(3) for biological DMARDs?
+ They slow more joint damage than traditional DMARDs - Expensive - parental route - Not all patients respond to biological therapy - More evidence is needed to know true therapeutic value and economic evaluation
67
Mechanism of action for Tofacitinib - 4 stages
- different cytokines, lymphokines and growth factors signal through cell surface receptor tyrosine kinase - Activated JAKs phosphorylate STAT - Tofacitinib as JAK inhibitor prevents phosphorylation of STAT - Therefore, Prevention of translocation of STAT dimer into nucleus and activation of gene transcription
68
Biological indicators summary | - Name 8 targets and the drug used to treat
- IL-6 - Tocilimumab - TNF - Infliximab, Etanercept, adalimumab - IL-1 - Anakinra - JAK - Tofacitinib - RANKL - Denosumab - CD80 - Abatacept - CD20 - Rituximab - SYK - Fostamatinib

MPH322 Musculoskeletal - RA (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions